StarBIA conducts and publishes research with universities, research institutes and hospitals in the field of body composition technologies, including bioelectrical impedance analysis from simple whole-body single-frequency mode to professional multi-segmental, multi-frequency mode. At this stage, StarBIA’s bioelectrical impedance analysis products are under Class II medical device applications of the Taiwan Food and Drug Administration (TFDA), the US Food and Drug Administration (USFDA), China Food and Drug Administration (CFDA) and the EU Medical Device Directive (MDD).